TD Asset Management
ORTX

TD Asset Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

TD Asset Management’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,511
Closed -$81K – 1566
2021
Q3 		$81K Hold
3,511
– – ﹤0.01% 1506
2021
Q2 		$101K Hold
3,511
– – ﹤0.01% 1500
2021
Q1 		$255K Buy
3,511
+975
+38% +$69.3K ﹤0.01% 1462
2020
Q4 		$110K Sell
2,536
-3,227
-56% -$145K ﹤0.01% 1429
2020
Q3 		$237K Sell
5,763
-3,354
-37% -$173K ﹤0.01% 1327
2020
Q2 		$547K Buy
9,117
+70
+0.8% +$6.41K ﹤0.01% 1192
2020
Q1 		$681K Sell
9,047
-2,810
-24% -$324K ﹤0.01% 1101
2019
Q4 		$1.63M Buy
11,857
+1,150
+11% +$140K ﹤0.01% 974
2019
Q3 		$1.27M Buy
10,707
+1,940
+22% +$271K ﹤0.01% 1006
2019
Q2 		$1.23M Buy
8,767
+4,272
+95% +$750K ﹤0.01% 1012
2019
Q1 		$804K Buy
4,495
+320
+8% +$48.1K ﹤0.01% 1087
2018
Q4 		$657K Buy
+4,175
New +$622K ﹤0.01% 1163

Other funds holding ORTX

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

TD Asset Management's ORTX Position: Q4 2021 in Review

TD Asset Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2021, closing a stake of 3,511 shares — an estimated $81K sold.

TD Asset Management first reported a position in ORTX in Q4 2018 and held it in 12 quarters. The position peaked at $1.63M in Q4 2019. 72 funds tracked by Wall St. Rank hold ORTX as of Q4 2021.

  • TD Asset Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • TD Asset Management sold 3,511 Orchard Therapeutics plc American Depositary Shares shares in Q4 2021, an estimated $81K.
  • TD Asset Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2018 and held it in 12 quarters.
  • TD Asset Management's Orchard Therapeutics plc American Depositary Shares position peaked at $1.63M in Q4 2019.
  • 72 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2021.

Based on TD Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.